GILD (STOCKS)
Gilead Sciences Inc
$126.160000
+1.860000 (+1.50%)
Prev close: $124.300000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel P. O'Day
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $157,989.78M
- Employees
- 17,600
- P/E (TTM)
- 16.91
- P/B (TTM)
- 6.57
- Dividend Yield
- 256.64%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
21
Buy
7
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$2.03 | $1.95 | +0.0775 | +3.97% |
|
Dec 2025 (Q4)
|
$1.86 | $1.85 | +0.0134 | +0.73% |
|
Sep 2025 (Q3)
|
$2.47 | $2.17 | +0.2972 | +13.68% |
|
Jun 2025 (Q2)
|
$2.01 | $2.00 | +0.0120 | +0.60% |
Financial Statements
| Revenues | $29.74B |
| Benefits Costs and Expenses | $19.01B |
| Cost Of Revenue | $6.14B |
| Costs And Expenses | $19.37B |
| Gross Profit | $23.60B |
| Nonoperating Income/Loss | $1.36B |
| Operating Expenses | $13.23B |
| Selling, General, and Administrative Expenses | $5.97B |
| Other Operating Expenses | $7.26B |
| Operating Income/Loss | $10.37B |
| Income/Loss From Continuing Operations After Tax | $9.22B |
| Income/Loss From Continuing Operations Before Tax | $10.73B |
| Income Tax Expense/Benefit | $1.51B |
| Income Tax Expense/Benefit, Deferred | $538.00M |
| Net Income/Loss | $9.22B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $9.22B |
| Net Income/Loss Available To Common Stockholders, Basic | $9.22B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.42 |
| Diluted Earnings Per Share | $7.34 |
| Basic Average Shares | 3,729,000,000 |
| Diluted Average Shares | 3,762,000,000 |
| Assets | $56.28B |
| Current Assets | $18.64B |
| Inventory | $1.91B |
| Other Current Assets | $16.73B |
| Noncurrent Assets | $37.64B |
| Fixed Assets | $5.64B |
| Intangible Assets | $16.38B |
| Other Non-current Assets | $15.62B |
| Liabilities | $32.85B |
| Current Liabilities | $9.48B |
| Accounts Payable | $645.00M |
| Other Current Liabilities | $8.83B |
| Noncurrent Liabilities | $23.37B |
| Long-term Debt | $22.17B |
| Other Non-current Liabilities | $1.20B |
| Equity | $23.43B |
| Equity Attributable To Noncontrolling Interest | -$84.00M |
| Equity Attributable To Parent | $23.52B |
| Liabilities And Equity | $56.28B |
| Net Cash Flow From Operating Activities | $10.81B |
| Net Cash Flow From Operating Activities, Continuing | $10.81B |
| Net Cash Flow From Investing Activities | -$2.61B |
| Net Cash Flow From Investing Activities, Continuing | -$2.61B |
| Net Cash Flow From Financing Activities | -$8.56B |
| Net Cash Flow From Financing Activities, Continuing | -$8.56B |
| Exchange Gains/Losses | $62.00M |
| Net Cash Flow | -$298.00M |
| Net Cash Flow, Continuing | -$360.00M |
| Comprehensive Income/Loss | $9.20B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $9.20B |
| Other Comprehensive Income/Loss | $2.01B |